Among the eleven GICS stock market sectors, Healthcare is one of the most valuable, and companies associated with the biotechnology industry represent a significant portion of that wealth.
The value is not only monetary: from cancer immunotherapies to novel diagnostic equipment and more, biotech companies are advancing human health at a historically unprecedented pace.
We have provided an overview of the top 50 biotech companies in the world based on market capitalization (the combined value of each company’s total stock shares) as of July 2022.
Collectively, these companies have a worth of over $4.5 trillion and are headquartered in countries around the globe.
Given that the combined wealth of companies in the Healthcare sector is approximately $7.5 trillion, these companies alone account for over half of that wealth.
25 of the companies are headquartered in the United States while 7 are in Japan, 3 in each China, Germany, and Switzerland, 2 in each the United Kingdom, India, and Denmark, 1 in each Ireland, Australia, and France.
At first place on the list is the biotechnology giant Johnson & Johnson, with a total worth of over $452 billion.
Neurocrine Biosciences, a California-based biopharmaceutical company developing treatments for neurological and endocrine diseases and disorders, ranks in last place with a market cap of $9.10 billion.
The Italian pharmaceutical company Recordati barely missed the list with a market cap of only $8.99 billion.
For a focused review of biotech companies developing immunotherapies for cancer and other diseases, consider checking out the ImmunoFrontiers ImmunoBiotech Viewspace.
Top 50 Biotech Companies of 2022
|Rank||Company||Value in Billions||Symbol|
|1||Johnson & Johnson||$452.91||JNJ|
|8||Thermo Fisher Scientific||$219.82||TMO|
|31||Jiangsu Hengrui Medicine||$36.34||600276.SS|
|43||Charles River Laboratories||$12.04||CRL|